• FryAI
  • Posts
  • $250 million isn't enough...

$250 million isn't enough...

FryAI

Happy Wednesday! While many are falling behind the fast-moving AI trends, we’ve got you covered with the latest to keep you on the cutting edge. 🦾

(The mystery link can lead to ANYTHING AI-related: tools, memes, articles, videos, and more…)

Today’s Menu

Appetizer: News Corp whines about money 😭

Entrée: Tesla gets sued over use of “Blade Runner” picture 🏎️

Dessert: GE HealthCare brings AI to cancer diagnostics 🙏

🔨 AI TOOLS OF THE DAY

📷 RenderNet: Generate images with character consistency. → Check it out

Clearspace (App): Complete wellness tasks to earn screen time. → Check it out

🫵 Facts Generator: Discover interesting facts about any topic. → Check it out

NEWS CORP WHINES ABOUT MONEY 😭

Q: How does an attorney sleep?

A: First, they lie on one side. Then, they lie on the other. 🙃

What’s going on? News Corp, the parent company of The Wall Street Journal and the New York Post, has sued Perplexity for allegedly using their content without permission.

What’s the claim? The lawsuit claims that Perplexity scraped copyrighted material to train its AI models without compensating the publishers. News Corp CEO Robert Thomson argued that Perplexity’s actions undermine the hard work of journalists. He stated, “The perplexing Perplexity has willfully copied copious amounts of copyrighted material without compensation, and shamelessly presents repurposed material as a direct substitute for the original source.” The company seeks $150,000 per infringement, which could financially cripple the startup if successful.

What’s really going on here? Perplexity, unlike many other LLMs, provides links at the end of its responses, citing the sources it pulled the data from. But this isn’t enough for Thompson, who states, “Perplexity proudly states that users can ‘skip the links’—apparently, Perplexity wants to skip the check.” Thompson says that he “applaud[s] OpenAI,” which gives no attribution to the authors, but wrote News Corp a fat check of $250 million in May to openly train AI models on their data. At the end of the day, Thompson doesn’t seem to care much about giving attribution to the authors—he just wants another check.

TESLA GETS SUED OVER USE OF “BLADE RUNNER” PICTURE 🏎️

A still from the “Blade Runner 2049” trailer (left) and from Tesla’s Live robotaxi event (right). Source: Warner Bros. Pictures | Tesla

Lawsuits be poppin’ today! 💸

What’s up? Elon Musk and Tesla are facing a lawsuit over alleged copyright infringement for the marketing of the new Cybercab.

Want the details? The lawsuit, filed by Alcon Entertainment, claims that Tesla used images from the movie “Blade Runner 2049” to promote its new robotaxi concept, the Cybercab, during the October 10 unveiling event. Alcon had previously denied Tesla permission to use these images but alleges that Tesla used an AI-generated version of the image anyway. The lawsuit accuses Musk and Tesla of economic theft and false endorsement. Alcon, which is currently in talks with automotive brands for a “Blade Runner 2099” TV series, emphasizes that it does not want its brand associated with Musk or Tesla.

GE HEALTHCARE BRINGS AI TO CANCER DIAGNOSTICS 🙏

Healthcare data is notoriously difficult to analyze, and as much as 97% of the data produced by hospitals goes unused. 😳

What’s new? GE HealthCare has unveiled CareIntellect for Oncology, an AI-powered tool designed to help doctors streamline cancer diagnosis and treatment.

How does this work? The application aims to reduce the time doctors spend sifting through complex patient records, providing quick summaries of patient histories and tracking disease progression. It can also identify clinical trials that may benefit patients, saving oncologists hours of manual research. This new tool is part of GE HealthCare’s larger AI initiative, which includes several other AI solutions in development. One upcoming project, Health Companion, will feature a team of AI agents specialized in different medical fields, designed to support doctors with real-time insights. CareIntellect for Oncology is expected to be available in the U.S. by 2025, with an initial focus on prostate and breast cancers.

“At the moment, it’s an early concept. Our aim is to elevate the standard of care and get ahead of the overburden of clinicians trying to take care of their patients.”

-Dr. Taha Kass-Hout, GE HealthCare’s global chief science and technology officer

“WATCH THIS” WEDNESDAY 👀

Self-driving cars are the future! This video breaks down the top 5 autonomous vehicles:

HAS AI REACHED SINGULARITY? CHECK OUT THE FRY METER BELOW:

What do ya think of this latest newsletter?

Login or Subscribe to participate in polls.